Syncona Partners LLP

company

About

Syncona Partners LLP is a healthcare company focused on investing in and building global leaders in life science.

  • 11 - 50

Details

Industries
Biotechnology,Financial Services,Health Care,Venture Capital
Founded date
Jan 1, 2012
Number Of Employee
11 - 50
Operating Status
Active
Investor Type
Venture Capital

Syncona is a leading healthcare company focused on investing in and building global leaders in life science. Their vision is to deliver transformational treatments to patients in truly innovative areas of healthcare while generating superior returns for shareholders.

They seek to partner with the best, brightest and most ambitious minds in science to build globally competitive businesses. They take a long-term view, underpinned by a deep pool of capital, and are established leaders in the development of genetic medicine, particularly gene and cell therapy. They focus on delivering dramatic efficacy for patients in areas of high unmet need.

Syncona is aligned with two of the premium charitable funders in UK science, The Wellcome Trust, original founder of Syncona, and Cancer Research UK, both of which are significant shareholders in their business. They make a donation of 0.3% of Net Asset Value to a range of charities each year.

Investments

Number of Investments
Number of Lead Investments
4
3
Syncona Partners LLP has made 4 investments. Their most recent investment was on Sep 14, 2020, when Neogene Therapeutics raised $110M.
Date Company Name
Round Money Raised Industry Lead Investor
Series A $110M Biotechnology Yes
Sep 26, 2017 Autolus
Series C $80M Biopharma
Series B £18M Biotechnology Yes
Jan 22, 2015 Autolus
Series A £30M Biopharma Yes